Middle East & Africa Respiratory Inhalers Market

Historic Data: 2020-2021   |   Base Year: 2022   |   Forecast Period: 2023-2028

Analysis – by Product Type [Nebulizers, Metered Dose Inhalers (MDI), and Dry Powder Inhalers], Technology (Manually Operated Inhalers and Digitally Operated Inhalers), and Disease Indication (Asthma, COPD, Pulmonary Arterial Hypertension, and Others)  

No. of Pages: 157
Report Code: BMIRE00028394
Category: Life Sciences
Middle East & Africa Respiratory Inhalers Market

1. Introduction

1.1 Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Data Triangulation and Validation

4. Middle East & Africa Respiratory Inhalers Market Landscape

4.1 Overview
4.3 Ecosystem Analysis
  • 4.3.1 List of Vendors in the Value Chain

5. Middle East & Africa Respiratory Inhalers Market – Key Market Dynamics

5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints

6. Middle East & Africa Respiratory Inhalers Market Regional Analysis

6.2 Middle East & Africa Respiratory Inhalers Market Revenue 2020-2028 (US$ Million)
6.3 Middle East & Africa Respiratory Inhalers Market Forecast Analysis

7. Middle East & Africa Respiratory Inhalers Market Analysis – by Product Type

7.1 Nebulizers
  • 7.1.1 Overview
  • 7.1.2 Nebulizers: Middle East & Africa Respiratory Inhalers Market – Revenue and Forecast, 2020-2028 (US$ Million)
7.2 Metered Dose Inhalers
  • 7.2.1 Overview
  • 7.2.2 Metered Dose Inhalers: Middle East & Africa Respiratory Inhalers Market – Revenue and Forecast, 2020-2028 (US$ Million)
7.3 Dry Powder Inhalers
  • 7.3.1 Overview
  • 7.3.2 Dry Powder Inhalers: Middle East & Africa Respiratory Inhalers Market – Revenue and Forecast, 2020-2028 (US$ Million)

8. Middle East & Africa Respiratory Inhalers Market Analysis – by Technology

8.1 Manually Operated Inhalers and Digitally Operated Inhalers
  • 8.1.1 Overview
  • 8.1.2 Manually Operated Inhalers and Digitally Operated Inhalers: Middle East & Africa Respiratory Inhalers Market – Revenue and Forecast, 2020-2028 (US$ Million)

9. Middle East & Africa Respiratory Inhalers Market Analysis – by Disease Indication

9.1 Asthma
  • 9.1.1 Overview
  • 9.1.2 Asthma: Middle East & Africa Respiratory Inhalers Market – Revenue and Forecast, 2020-2028 (US$ Million)
9.2 COPD
  • 9.2.1 Overview
  • 9.2.2 COPD: Middle East & Africa Respiratory Inhalers Market – Revenue and Forecast, 2020-2028 (US$ Million)
9.3 Pulmonary Arterial Hypertension
  • 9.3.1 Overview
  • 9.3.2 Pulmonary Arterial Hypertension: Middle East & Africa Respiratory Inhalers Market – Revenue and Forecast, 2020-2028 (US$ Million)

10. Middle East & Africa Respiratory Inhalers Market – Middle East and Africa Analysis

10.1 Overview

10.2 Middle East and Africa
  • 10.2.1 Middle East & Africa Respiratory Inhalers Market Breakdown, by Key Country, 2023 and 2028 (%)
  • 10.2.1.1 Middle East & Africa Respiratory Inhalers Market – Revenue and Forecast Analysis – by Country
  • 10.2.1.1 South Africa: Middle East & Africa Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.2.1.1.1 South Africa: Middle East & Africa Respiratory Inhalers Market Breakdown, by Product Type
    • 10.2.1.1.2 South Africa: Middle East & Africa Respiratory Inhalers Market Breakdown, by Technology
    • 10.2.1.1.3 South Africa: Middle East & Africa Respiratory Inhalers Market Breakdown, by Disease Indication
  • 10.2.1.2 Saudi Arabia: Middle East & Africa Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.2.1.2.1 Saudi Arabia: Middle East & Africa Respiratory Inhalers Market Breakdown, by Product Type
    • 10.2.1.2.2 Saudi Arabia: Middle East & Africa Respiratory Inhalers Market Breakdown, by Technology
    • 10.2.1.2.3 Saudi Arabia: Middle East & Africa Respiratory Inhalers Market Breakdown, by Disease Indication
  • 10.2.1.3 UAE: Middle East & Africa Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.2.1.3.1 UAE: Middle East & Africa Respiratory Inhalers Market Breakdown, by Product Type
    • 10.2.1.3.2 UAE: Middle East & Africa Respiratory Inhalers Market Breakdown, by Technology
    • 10.2.1.3.3 UAE: Middle East & Africa Respiratory Inhalers Market Breakdown, by Disease Indication
  • 10.2.1.4 Rest of Middle East and Africa: Middle East & Africa Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.2.1.4.1 Rest of Middle East and Africa: Middle East & Africa Respiratory Inhalers Market Breakdown, by Product Type
    • 10.2.1.4.2 Rest of Middle East and Africa: Middle East & Africa Respiratory Inhalers Market Breakdown, by Technology
    • 10.2.1.4.3 Rest of Middle East and Africa: Middle East & Africa Respiratory Inhalers Market Breakdown, by Disease Indication

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments

13. Company Profiles

13.1 AstraZeneca Plc
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 Beximco Pharmaceuticals Ltd.
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 Boehringer Ingelheim International GmbH
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 Cipla Ltd
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 GSK Plc
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 Koninklijke Philips NV
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 OMRON Corp
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 OPKO Health, Inc
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments
13.9 PARI Respiratory Equipment, Inc.
  • 13.9.1 Key Facts
  • 13.9.2 Business Description
  • 13.9.3 Products and Services
  • 13.9.4 Financial Overview
  • 13.9.5 SWOT Analysis
  • 13.9.6 Key Developments
13.10 Teva Pharmaceutical Industries Ltd
  • 13.10.1 Key Facts
  • 13.10.2 Business Description
  • 13.10.3 Products and Services
  • 13.10.4 Financial Overview
  • 13.10.5 SWOT Analysis
  • 13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights
14.2 List of Abbreviations

The List of Companies - Middle East & Africa Respiratory Inhalers Market

  • AstraZeneca Plc
  • Beximco Pharmaceuticals Ltd.
  • Boehringer Ingelheim International GmbH
  • Cipla Ltd
  • GSK Plc
  • Koninklijke Philips NV
  • OMRON Corp
  • OPKO Health, Inc
  • PARI Respiratory Equipment, Inc.
  • Teva Pharmaceutical Industries Ltd
  • Available Report Formats

    pdf-format excel-format pptx-format
    Buy Now
    Customization Form

    Please tell us your area of interest
    (Market Segments/ Regions and Countries/ Companies)